IMUC Projected Dividend Yield
Com par $0.0001/EOM Pharmaceutical Holdings Inc ( OTCBB : IMUC )EOM Pharmaceutical Holdings, Inc. is a clinical-stage pharmaceutical company. Co. is focused on developing novel drugs for patients suffering from debilitating and deadly diseases, including infectious diseases; autoimmune diseases including rheumatoid arthritis; and cachexia associated with acquired immune deficiency syndrome (AIDS) and cancer. It has two pipeline assets in their portfolio: EOM613 and EOM147. EOM613 is an investigational immunomodulator. EOM613 is a peptide-nucleic acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects. 21 YEAR PERFORMANCE RESULTS |
IMUC Dividend History Detail IMUC Dividend News IMUC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |